Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
14 Jun 2010 07:00 AM
RNS
TWO-YEAR PHASE I/II RESULTS O
27 May 2010 10:28 AM
RNS
BLOCK LISTING SIX MONTHLY RET
19 May 2010 07:00 AM
RNS
Interim Management Statement
13 May 2010 07:00 AM
RNS
OXB to present at the Rodman
05 May 2010 11:39 AM
RNS
Notification of Major Interes
04 May 2010 10:23 AM
RNS
Total Voting Rights Update
27 Apr 2010 12:46 PM
RNS
Annual General Meeting
21 Apr 2010 07:00 AM
RNS
Board Change
09 Apr 2010 04:40 PM
RNS
Second Price Monitoring Extn
09 Apr 2010 04:35 PM
RNS
Price Monitoring Extension
01 Apr 2010 03:54 PM
RNS
Annual Information Update
31 Mar 2010 12:16 PM
RNS
Total Voting Rights Update
29 Mar 2010 05:27 PM
RNS
2009 ANNUAL REPORT AND ACCOUN
10 Mar 2010 07:00 AM
RNS
Preliminary Results
26 Feb 2010 09:14 AM
RNS
Total Voting Rights Update
17 Feb 2010 10:10 AM
RNS
Notice of Results
29 Jan 2010 11:28 AM
RNS
Total Voting Rights
27 Jan 2010 01:00 PM
RNS
Collaboration extension
27 Jan 2010 07:00 AM
RNS
Global settlement
22 Jan 2010 07:00 AM
RNS
Licence agreement
20 Jan 2010 07:00 AM
RNS
European Orphan Drug Designat
05 Jan 2010 07:00 AM
RNS
Management and Board Changes
15 Dec 2009 07:00 AM
RNS
EU orphan drug designation
11 Dec 2009 04:40 PM
RNS
Second Price Monitoring Extn
11 Dec 2009 04:35 PM
RNS
Price Monitoring Extension
03 Dec 2009 07:00 AM
RNS
Holding(s) in Company
27 Nov 2009 12:16 PM
RNS
Block Listing Six Monthly Ret
19 Nov 2009 07:00 AM
RNS
Interim Management Statement
30 Oct 2009 11:37 AM
RNS
Total Voting Rights Update
19 Oct 2009 02:14 PM
RNS
Holding(s) in Company
15 Oct 2009 07:00 AM
RNS
Prosavin Update
14 Oct 2009 04:40 PM
RNS
Second Price Monitoring Extn
14 Oct 2009 04:35 PM
RNS
Price Monitoring Extension
08 Oct 2009 04:40 PM
RNS
Second Price Monitoring Extn
08 Oct 2009 04:35 PM
RNS
Price Monitoring Extension
30 Sep 2009 10:50 AM
RNS
Total Voting Rights Update
22 Sep 2009 07:00 AM
RNS
Phase III Trist Study of Trov
04 Sep 2009 07:00 AM
RNS
Rodman & Renshaw Conference
01 Sep 2009 07:00 AM
RNS
Director's Interest in Shares
28 Aug 2009 03:59 PM
RNS
Total Voting Rights Update
27 Aug 2009 07:00 AM
RNS
Interim Results
19 Aug 2009 07:00 AM
RNS
Trovax Presentation at ECCO 1
07 Aug 2009 07:00 AM
RNS
Canaccord Adams Global Growth
06 Aug 2009 04:40 PM
RNS
Second Price Monitoring Extn
06 Aug 2009 04:35 PM
RNS
Price Monitoring Extension
06 Aug 2009 07:00 AM
RNS
Time change of Analyst briefi
05 Aug 2009 07:00 AM
RNS
Notice of Interim Results
13 Jul 2009 07:00 AM
RNS
ProSavin PhI/II study
09 Jul 2009 04:40 PM
RNS
Second Price Monitoring Extn
09 Jul 2009 04:35 PM
RNS
Price Monitoring Extension

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings